Back

A robust and versatile nanobody platform for drug delivery

Shen, Z.; Xiang, Y.; Vergara, S.; Chen, A.; Xiao, Z.; Santiago, U.; Jin, C.; Sang, Z.; Luo, J.; Chen, K.; Schneidman-Duhovny, D.; Camacho, C. J.; Calero, G.; Hu, B.; Shi, Y.

2020-08-20 bioengineering
10.1101/2020.08.19.257725 bioRxiv
Show abstract

Therapeutic and diagnostic efficacies of numerous small biomolecules and chemical compounds are hampered by the short half-lives. Here we report the development of a repertoire of diverse, high-affinity albumin-nanobodies (NbHSA) to facilitate drug delivery. By integrating biophysics, and hybrid structural biology, we have systematically characterized the NbHSA for albumin binding, mapped the epitopes, and resolved the architecture of a tetrameric Nb-albumin complex. We employed quantitative proteomics for accurate, multiplex Nb pharmacokinetic analysis. Using a humanized albumin mouse model, we found that the NbHSA has outstanding pharmacokinetics; the most stable NbHSA has a 771-fold T1/2 improvement compared with a control Nb. Interestingly, the pharmacokinetics of NbHSA is related to their biophysical and structural properties. To demonstrate the utility of NbHSA, we developed a highly stable NbHSA-hIL-2 cytokine conjugate "Duraleukin" and confirmed its improved anticancer properties than hIL-2 alone. We envision that this high-quality Nb resource will advance research into novel biotherapeutics.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Nature Communications
○ 5641 papers in training set
Top 6%
22.3%
Similar papers in this journal
2
ACS Central Science
● 71 papers in training set
Top 0.1%
8.0%
Similar papers in this journal
3
Advanced Science
○ 286 papers in training set
Top 0.5%
8.0%
Similar papers in this journal
4
Angewandte Chemie International Edition
○ 93 papers in training set
Top 0.2%
6.8%
Similar papers in this journal
5
Science Advances
● 1243 papers in training set
Top 3%
6.8%
Similar papers in this journal
50% of probability mass above
6
ACS Nano
● 113 papers in training set
Top 0.4%
4.9%
7
Cell Chemical Biology
○ 94 papers in training set
Top 0.3%
3.5%
8
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 16%
3.2%
9
Communications Biology
○ 993 papers in training set
Top 8%
2.4%
10
Journal of the American Chemical Society
● 217 papers in training set
Top 2%
1.9%
11
Nature Biomedical Engineering
○ 47 papers in training set
Top 1.0%
1.5%
12
eLife
● 5828 papers in training set
Top 56%
1.4%
13
Cell Reports
○ 1498 papers in training set
Top 22%
1.1%
14
Nature Nanotechnology
○ 32 papers in training set
Top 0.4%
1.1%
15
Nano Letters
● 71 papers in training set
Top 0.9%
1.1%
16
Nature Chemical Biology
○ 119 papers in training set
Top 2%
1.1%
17
iScience
○ 1154 papers in training set
Top 25%
1.1%
18
Analytical Chemistry
● 218 papers in training set
Top 2%
1.1%
19
Nature Chemistry
○ 42 papers in training set
Top 0.6%
1.1%
20
Cell Discovery
○ 57 papers in training set
Top 0.8%
1.1%
21
Signal Transduction and Targeted Therapy
○ 30 papers in training set
Top 0.5%
1.0%
22
Nature Biotechnology
○ 172 papers in training set
Top 4%
0.9%
23
Biomaterials
○ 84 papers in training set
Top 2%
0.9%
24
Cell Reports Medicine
○ 153 papers in training set
Top 5%
0.9%
25
mAbs
○ 32 papers in training set
Top 0.5%
0.6%
26
Cell Research
○ 51 papers in training set
Top 2%
0.6%
27
Nature Methods
○ 385 papers in training set
Top 7%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.